| # | Drug | Count |
|---|---|---|
| 0 | AZATHIOPRINE | 10 |
| 1 | TACROLIMUS | 8 |
| 2 | ALLOPURINOL | 6 |
| 3 | PREDNISONE | 6 |
| 4 | LEVETIRACETAM | 5 |
| 5 | LEVETIRACETAM IN SODIUM CHLORIDE | 5 |
| 6 | LEVETIRACETAM INJECTION | 5 |
| 7 | LEVETIRACETAM ORAL | 5 |
| 8 | RITUXIMAB | 4 |
| 9 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BETAMETHASONE ACETATE AND BETAMETHASONE SODIUM PHOSPHATE | 1 | 0.0025 |
| 1 | HUMAN RHO(D) IMMUNE GLOBULIN | 1 | 0.0010 |
| 2 | PROBENECID | 1 | 0.0008 |
| 3 | CEFUROXIME AXETIL | 2 | 0.0006 |
| 4 | PYRIDOXINE HYDROCHLORIDE | 1 | 0.0004 |
| 5 | AZATHIOPRINE | 10 | 0.0001 |
| 6 | ZIDOVUDINE | 1 | 0.0001 |
| 7 | DOXORUBICIN HYDROCHLORIDE | 3 | 0.0001 |
| 8 | PIPERACILLIN AND TAZOBACTAM | 1 | 0.0001 |
| 9 | MAGNESIUM SULFATE HEPTAHYDRATE | 1 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 10 |
| 1 | Purine Antimetabolite [EPC] | 10 |
| 2 | Xanthine Oxidase Inhibitor [EPC] | 6 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 4 |
| 4 | Vitamin B12 [EPC] | 3 |
| 5 | Vitamin C [EPC] | 3 |
| 6 | Vitamin D [EPC] | 3 |
| 7 | Alkylating Drug [EPC] | 2 |
| 8 | Atypical Antipsychotic [EPC] | 1 |
| 9 | Benzodiazepine [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Purine Antimetabolite [EPC] | 10 | 0.0001 |
| 1 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 1 | 0.0001 |
| 2 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 3 | Xanthine Oxidase Inhibitor [EPC] | 6 | 0.0000 |
| 4 | General Anesthetic [EPC] | 1 | 0.0000 |
| 5 | Central alpha-2 Adrenergic Agonist [EPC] | 1 | 0.0000 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 4 | 0.0000 |
| 7 | Vitamin D [EPC] | 3 | 0.0000 |
| 8 | Vitamin B12 [EPC] | 3 | 0.0000 |
| 9 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |